In the studies on NXP2 antibodies included in our meta-analysis, there was one study in which only juvenile IIM was investigated [49], and another study in which juvenile IIM patients were included in addition to adult patients [47]. The gene discussed is MORC3; the disease is acquired idiopathic inflammatory myopathy.